Plant Biotechnology, Plant Viruses, and Pharmaceuticals
In February 2023, Mitsubishi Chemical Group announced its decision to stop Medicago Inc.’s operations. Medicago was a pharmaceutical company based in Quebec, Canada that made headlines at the height of the COVID-19 pandemic when it successfully used plant molecular farming to create COVIFENZ® COVID-19 vaccine. The company is regarded as a pioneer in its field, and its closure has left people wondering about the future of using plant-based technology in producing vaccines and other pharmaceutical products.
Achieving Balance in Marine Biotechnology Research
New Double Helix Focuses on Gene Editing
What Lies Ahead for Gene-edited Crops?
10 Tips to Effectively Communicate Biotech for Scientists
Science Speaks is ISAAA Inc.'s official blog. Weekly blog articles, authored by ISAAA writers, partners, and invited contributors, aim to help share, disseminate, and promote scientific knowledge and its vital role in achieving global agricultural sustainability and development. Your support to Science Speaks will help us achieve this goal. You can help us by donating as little as $10.